CRV
Listed as “Switch Therapeutics”
- First observed:
- 31 Oct 2026
- Investment announced:
- Date not recorded
Switch Therapeutics
Company website description: Switch Therapeutics is a biotech company dedicated to revolutionizing RNA interference (RNAi) therapies with conditionally activated siRNAs (CASi).
- Tracked VC backers
- 1
Publicly documented VC backing
These sources establish that the firm lists the company. The observation date records when RiseFinder captured the relationship; it does not establish when the investment happened.
Dated public activity
No dated funding or investment events are recorded yet. Initial portfolio listings establish the starting baseline and earn no points.